Jacot, William <br/><br/>
Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.  [electronic resource] 

 -  Breast cancer research and treatment  06 2016 
 - 307-318 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-016-3828-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Ado-Trastuzumab Emtansine<br/>Adult<br/>Aged<br/>Antineoplastic Agents, Immunological--administration & dosage<br/>Brain Neoplasms--genetics<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Maytansine--administration & dosage<br/>Middle Aged<br/>Receptor, ErbB-2--genetics<br/>Retrospective Studies<br/>Survival Analysis<br/>Trastuzumab--administration & dosage<br/>Treatment Outcome